These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3109897

  • 1. In vitro activity of RO 15-8074 and RO 19-5247.
    Valle T, Jalanko E, Scheinin L, Renkonen OV.
    Eur J Clin Microbiol; 1987 Apr; 6(2):167-9. PubMed ID: 3109897
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
    Neu HC, Chin NX, Labthavikul P.
    Antimicrob Agents Chemother; 1986 Sep; 30(3):423-8. PubMed ID: 3490827
    [Abstract] [Full Text] [Related]

  • 5. Comparative antimicrobial activity of ceftibuten against multiply-resistant microorganisms from Belgium.
    Verbist L, Jacobs J, Hens K.
    Diagn Microbiol Infect Dis; 1991 Sep; 14(1):53-61. PubMed ID: 1901535
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites.
    Wise R, Andrews JM, Piddock LJ.
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1067-72. PubMed ID: 3729361
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
    Chau PY, Leung YK, Ng WW, Arnold K.
    Antimicrob Agents Chemother; 1987 Mar; 31(3):473-6. PubMed ID: 3579264
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
    Bowie WR, Shaw CE, Chan DG, Black WA.
    Antimicrob Agents Chemother; 1987 Mar; 31(3):470-2. PubMed ID: 2953304
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
    Beskid G, Fallat V, Siebelist J, Durkin JW, Lipschitz ER, McGarry DH.
    J Clin Microbiol; 1987 Jul; 25(7):1186-90. PubMed ID: 3112176
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.
    Le Saux NM, Slaney LA, Plummer FA, Ronald AR, Brunham RC.
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1153-4. PubMed ID: 2959199
    [Abstract] [Full Text] [Related]

  • 11. In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins.
    Fass RJ, Helsel VL.
    Antimicrob Agents Chemother; 1986 Sep; 30(3):429-34. PubMed ID: 3777906
    [Abstract] [Full Text] [Related]

  • 12. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
    Bill NJ, Washington JA.
    Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
    [Abstract] [Full Text] [Related]

  • 13. In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
    Angehrn P, Hohl P, Then RL.
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):536-43. PubMed ID: 2504597
    [Abstract] [Full Text] [Related]

  • 14. The activity of the 4 quinolone Ro 23 6240 and the cephalosporins Ro 15 8074 and Ro 19 5247 against penicillin sensitive and resistant gonococci.
    Easmon CS, Woodford N, Ison CA.
    J Antimicrob Chemother; 1987 Jun; 19(6):761-5. PubMed ID: 3112100
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of cefpodoxime in comparison with other oral beta-lactam antibiotics.
    Kayser FH.
    Infection; 1994 Jun; 22(5):370-5. PubMed ID: 7843823
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of BAY v 3522, a new oral cephalosporin.
    Fass RJ.
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1855-7. PubMed ID: 2126697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.